Wearable Plasmonic Sweat Biosensor for Acetaminophen Drug Monitoring

Monitoring the acetaminophen dosage is important to prevent the occurrence of adverse reactions such as liver failure and kidney damage. Traditional approaches to monitoring acetaminophen dosage mainly rely on invasive blood collection. Herein, we developed a noninvasive microfluidic-based wearable plasmonic sensor to achieve simultaneous sweat sampling and acetaminophen drug monitoring for vital signs. The fabricated sensor employs an Au nanosphere cone array as the key sensing component, which poses a substrate with surface-enhanced Raman scattering (SERS) activity to noninvasively and sensitively detect the fingerprint of acetaminophen molecules based on its unique SERS spectrum. The developed sensor enabled the sensitive detection and quantification of acetaminophen at concentrations as low as 0.13 mu M. We further evaluated the sweat sensor integrated with a Raman spectrometer for monitoring acetaminophen in drug-administered subjects. These results indicated that the sweat sensor could measure acetaminophen levels and reflect drug metabolism. The sweat sensors have revolutionized wearable sensing technology by adopting label-free and sensitive molecular tracking methods for noninvasive and point-of-care drug monitoring and management.

Automated summary

Monitoring the dosage of acetaminophen is crucial to prevent adverse reactions. In this study, a noninvasive wearable plasmonic sensor was developed for simultaneous sweat sampling and acetaminophen drug monitoring. The sensor employed a gold nanosphere cone array as the key component, enabling sensitive and noninvasive detection of acetaminophen molecules. The results showed that this sensor could accurately measure acetaminophen levels and reflect drug metabolism. The sweat sensor has revolutionized wearable sensing technology for noninvasive and point-of-care drug monitoring.